Valeda® Light Therapy Arrives at Vision Solutions to Treat Dry Age-Related Macular Degeneration

A New Treatment Breakthrough for Patients with Dry Age-Related Macular Degeneration (AMD)

September 21, 2026

Vision Solutions now offers Valeda® photobiomodulation (PBM) therapy, the first FDA-authorized in-office light treatment designed to help improve vision in appropriate patients with dry age-related macular degeneration (AMD).

Why This Matters

Dry AMD is one of the leading causes of vision loss in adults over 55. It affects the macula — the part of the retina responsible for the sharp central vision we rely on to read, drive, and recognize faces. For a long time, the guidance for dry AMD was mostly to keep up with regular eye exams and manage risk factors. There wasn't much else we could offer.

Valeda changes that.

How Valeda Works

The Valeda Light Delivery System, made by LumiThera, Inc., uses a combination of yellow, red, and near-infrared light to gently stimulate retinal cells. This supports the eye's natural energy production and helps clear cellular waste (drusen) — processes that tend to slow down as dry AMD progresses.

In the clinical trial that supported the treatment's FDA authorization, patients gained an average of more than five letters of visual acuity — about one line on a standard eye chart — after roughly a year of treatment. Treated patients were also significantly less likely to develop geographic atrophy, a more advanced form of dry AMD.

What Treatment Looks Like

Sessions are quick and comfortable:

•       About 4 minutes per eye

•       No needles, no dilation, no downtime

•       A full treatment cycle is 9 sessions over 3 to 5 weeks

 

A Message from Dr. Austin Boice

“For years, the options we could offer patients with dry age-related macular degeneration were largely focused on monitoring the condition and supporting overall eye health. What excites our whole team about Valeda is that it gives us a treatment option — not just something to monitor. We've seen firsthand how much anxiety can come with a dry AMD diagnosis, and being able to offer Valeda light therapy changes how that first conversation with a patient can go.”

Investing in Your Vision

Valeda is not currently covered by Medicare or private insurance. We've put together straightforward package pricing, including options for a full year of treatment, so patients can plan ahead. Because AMD is a progressive condition, our goal is to make this treatment as accessible as possible now, rather than waiting on insurance coverage to catch up.

Click for more information, FAQs, and Valeda packages

Is Valeda Right for You?

If you have dry AMD, or you're wondering whether you might be a candidate, we'd love to talk with you. Schedule an eye exam and  Valeda evaluation at any of our three locations — Lamar, Nevada, or Webb City — by visiting myvisionsolutions.com or calling your nearest office.

LAMAR: (417) 682-3301
NEVADA: (417) 667-2560
WEBB CITY: (417) 250-2828


If you're a physician or medical professional interested in referring a patient, please contact Dr. Austin Boice at (417) 682-3301.

  

This information is for educational purposes only and is not a substitute for a personalized evaluation with a licensed eye care provider. Individual results may vary. Important product information can be found at myalcon.com/amd/valeda-pbm.

Helpful Articles